The AFP Tumor Marker Test is designed to detect alpha-fetoprotein (AFP), a key biomarker often elevated in cases of primary liver cancer. This test supports early screening, diagnosis, and monitoring of liver tumors in veterinary patients. With high sensitivity and specificity, it helps identify abnormal AFP levels, allowing for timely clinical decisions and improved treatment outcomes. Ideal for use in routine health checks or when liver disease is suspected, the AFP Tumor Marker Test is a valuable tool for veterinarians aiming to detect hepatic malignancies early and manage liver health proactively.